Family · Pharmaceutical analytical standards
Ceftibuten
An oral third-generation cephalosporin antibiotic. Approved in the United States in 1995, it is used for respiratory tract infections such as otitis media, pharyngitis, tonsillitis and flare-ups of chronic bronchitis; in other countries also for urinary infections. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Thirty years on it is back in the spotlight: paired with ledaborbactam, a boron-based beta-lactamase inhibitor, it is being studied as an oral antibiotic against multidrug-resistant Enterobacterales, including carbapenemase producers.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
